TFF Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Austin, TX
SEC filing record 1 source field available
Fiscal year end
31 December
TFF Pharmaceuticals, Inc. has filed 317 SEC EDGAR filings since 27 Mar 2018

SEC filing history

Showing 176-200 of 317 matching filings.

Per page
25
Current page
8
SC 13G/A File 005-91311

SC 13G/A

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-261896

REGISTRATION STATEMENT

Filing date
27 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39102

CURRENT REPORT

Filing date
21 Dec 2021
Reporting date
21 Dec 2021
Next action
Verify source filing
8-K File 001-39102

CURRENT REPORT

Filing date
16 Nov 2021
Reporting date
15 Nov 2021
Next action
Verify source filing
10-Q File 001-39102

QUARTERLY REPORT

Filing date
15 Nov 2021
Reporting date
30 Sep 2021
Next action
Verify source filing
8-K File 001-39102

CURRENT REPORT

Filing date
10 Nov 2021
Reporting date
04 Nov 2021
Next action
Verify source filing
4

4 filing

Filing date
24 Sep 2021
Reporting date
22 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39102

DEFINITIVE PROXY STATEMENT

Filing date
23 Sep 2021
Reporting date
04 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
16 Sep 2021
Reporting date
16 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Sep 2021
Reporting date
16 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-39102

QUARTERLY REPORT

Filing date
12 Aug 2021
Reporting date
30 Jun 2021
Next action
Verify source filing
8-K File 001-39102

CURRENT REPORT

Filing date
12 Aug 2021
Reporting date
12 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 May 2021
Reporting date
19 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 May 2021
Reporting date
18 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-39102

QUARTERLY REPORT

Filing date
13 May 2021
Reporting date
31 Mar 2021
Next action
Verify source filing
8-K File 001-39102

CURRENT REPORT

Filing date
13 May 2021
Reporting date
13 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-39102

AMENDMENT NO. 1 TO FORM 10-K

Filing date
29 Apr 2021
Reporting date
31 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
30 Mar 2021
Reporting date
26 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-249870

PROSPECTUS SUPPLEMENT

Filing date
29 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39102

CURRENT REPORT

Filing date
26 Mar 2021
Reporting date
26 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-249870

PROSPECTUS SUPPLEMENT

Filing date
26 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
17 Mar 2021
Reporting date
15 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Mar 2021
Reporting date
15 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
17 Mar 2021
Reporting date
15 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-39102

ANNUAL REPORT

Filing date
10 Mar 2021
Reporting date
31 Dec 2020
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .